Menora Mivtachim Holdings LTD. Purchases 625,000 Shares of GE HealthCare Technologies Inc. $GEHC

Menora Mivtachim Holdings LTD. increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 57.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,715,250 shares of the company’s stock after acquiring an additional 625,000 shares during the period. Menora Mivtachim Holdings LTD. owned about 0.38% of GE HealthCare Technologies worth $128,815,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the company. Empowered Funds LLC boosted its holdings in shares of GE HealthCare Technologies by 6.1% in the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after purchasing an additional 1,665 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of GE HealthCare Technologies during the 1st quarter worth $259,000. Wedbush Securities Inc. raised its holdings in shares of GE HealthCare Technologies by 6.0% during the 2nd quarter. Wedbush Securities Inc. now owns 4,628 shares of the company’s stock worth $343,000 after buying an additional 262 shares in the last quarter. Prospera Financial Services Inc lifted its position in shares of GE HealthCare Technologies by 198.7% during the 2nd quarter. Prospera Financial Services Inc now owns 14,167 shares of the company’s stock worth $1,050,000 after buying an additional 9,424 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC bought a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth $854,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Down 3.2%

Shares of GEHC stock opened at $70.33 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $89.77. The stock’s fifty day simple moving average is $81.02 and its 200 day simple moving average is $78.51. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The firm has a market capitalization of $32.05 billion, a P/E ratio of 15.42, a P/E/G ratio of 1.60 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same period last year, the company earned $1.45 earnings per share. The business’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Analysts Set New Price Targets

A number of research analysts have issued reports on GEHC shares. Stifel Nicolaus lifted their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their target price for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Jefferies Financial Group raised their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Finally, Morgan Stanley upped their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.